000 01440 a2200397 4500
005 20250513190422.0
264 0 _c19990819
008 199908s 0 0 eng d
022 _a0031-4005
024 7 _a10.1542/peds.104.2.231
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDavidson, D
245 0 0 _aSafety of withdrawing inhaled nitric oxide therapy in persistent pulmonary hypertension of the newborn.
_h[electronic resource]
260 _bPediatrics
_cAug 1999
300 _a231-6 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdministration, Inhalation
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDouble-Blind Method
650 0 4 _aExtracorporeal Membrane Oxygenation
650 0 4 _aHumans
650 0 4 _aHypertension, Pulmonary
_xdrug therapy
650 0 4 _aNitric Oxide
_xadministration & dosage
650 0 4 _aTreatment Failure
650 0 4 _aTreatment Outcome
650 0 4 _aVasodilator Agents
_xadministration & dosage
700 1 _aBarefield, E S
700 1 _aKattwinkel, J
700 1 _aDudell, G
700 1 _aDamask, M
700 1 _aStraube, R
700 1 _aRhines, J
700 1 _aChang, C T
773 0 _tPediatrics
_gvol. 104
_gno. 2 Pt 1
_gp. 231-6
856 4 0 _uhttps://doi.org/10.1542/peds.104.2.231
_zAvailable from publisher's website
999 _c10386929
_d10386929